Literature DB >> 31235534

The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats.

Jenny L Wilkerson1, Jasmine S Felix2, Luis F Restrepo2, Mohd Imran Ansari2, Andrew Coop2, Lance R McMahon2.   

Abstract

Better therapeutic options are needed for pain. Baclofen, buspirone, and morphine are characterized as having analgesic properties. However, little is known about potential interactions between analgesic effects of these drugs when combined. Furthermore, it is not known if the magnitude of these potential interactions will be similar for all drug effects. Thus, we tested the effects of these drugs alone and in combination for their capacity to produce thermal antinociception and to decrease food-maintained responding. Four male and four female Sprague-Dawley rats responded for food under a fixed-ratio 10 schedule; afterward they were immediately placed on a 52°C hot plate. Morphine, baclofen, and buspirone were examined alone and in 1:1 combinations, based upon ED50 values. Morphine and baclofen effects were evaluated with the opioid antagonist naltrexone and the GABAB antagonist (3-Aminopropyl)(diethoxymethyl)phosphinic acid (CGP35348), respectively. Morphine, baclofen, and buspirone dose dependently decreased operant responding, with the calculated ED50 values being 7.09, 3.42, and 0.57 mg/kg, respectively. The respective antinociception ED50 values were 16.15, 8.75, and 2.20 mg/kg. Analysis of 1:1 combinations showed the effects of morphine plus baclofen to decrease schedule-controlled responding and to produce thermal antinociception were synergistic. Effects of morphine plus buspirone and baclofen plus buspirone to decrease schedule-controlled responding were additive. Effects of the two combinations to produce thermal antinociception were synergistic. Naltrexone and CGP35348 antagonized the effects of morphine and baclofen, respectively. Synergistic antinociceptive effects, in conjunction with additive effects on food-maintained responding, highlight the therapeutic utility of opioid and non-opioid drug combinations.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31235534      PMCID: PMC6697778          DOI: 10.1124/jpet.118.255844

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  45 in total

1.  Coding of facial expressions of pain in the laboratory mouse.

Authors:  Dale J Langford; Andrea L Bailey; Mona Lisa Chanda; Sarah E Clarke; Tanya E Drummond; Stephanie Echols; Sarah Glick; Joelle Ingrao; Tammy Klassen-Ross; Michael L Lacroix-Fralish; Lynn Matsumiya; Robert E Sorge; Susana G Sotocinal; John M Tabaka; David Wong; Arn M J M van den Maagdenberg; Michel D Ferrari; Kenneth D Craig; Jeffrey S Mogil
Journal:  Nat Methods       Date:  2010-05-09       Impact factor: 28.547

2.  Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study.

Authors:  M A Klitenick; P DeWitte; P W Kalivas
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

3.  Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia.

Authors:  S Stevens Negus; Edward J Bilsky; Gail Pereira Do Carmo; Glenn W Stevenson
Journal:  Methods Mol Biol       Date:  2010

4.  An overview of drug combination analysis with isobolograms.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2006-05-02       Impact factor: 4.030

Review 5.  The tetrapartite synapse: path to CNS sensitization and chronic pain.

Authors:  Joyce A De Leo; Vivianne L Tawfik; Michael L LaCroix-Fralish
Journal:  Pain       Date:  2006-03-29       Impact factor: 6.961

6.  The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat.

Authors:  J H Hwang; T L Yaksh
Journal:  Pain       Date:  1997-03       Impact factor: 6.961

7.  Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance.

Authors:  A A Larson; A E Takemori
Journal:  Life Sci       Date:  1977-12-15       Impact factor: 5.037

Review 8.  Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human.

Authors:  Michael M Morgan; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

9.  Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat.

Authors:  Paola Fadda; Maria Scherma; Alessandra Fresu; Maria Collu; Walter Fratta
Journal:  Synapse       Date:  2003-10       Impact factor: 2.562

10.  Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice.

Authors:  Jenny L Wilkerson; Zachary A Curry; Pamela D Kinlow; Brittany L Mason; Ku-Lung Hsu; Mario van der Stelt; Benjamin F Cravatt; Aron H Lichtman
Journal:  Pain       Date:  2018-06       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.